#schizophrenia — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #schizophrenia, aggregated by home.social.
-
In a Heat Wave, Schizophrenia Is So Much Deadlier Than Any Other Medical Condition | WIRED
https://www.wired.com/story/heat-wave-schizophrenia/ -
In a Heat Wave, Schizophrenia Is So Much Deadlier Than Any Other Medical Condition | WIRED
https://www.wired.com/story/heat-wave-schizophrenia/ -
In a Heat Wave, Schizophrenia Is So Much Deadlier Than Any Other Medical Condition | WIRED
https://www.wired.com/story/heat-wave-schizophrenia/ -
In a Heat Wave, Schizophrenia Is So Much Deadlier Than Any Other Medical Condition | WIRED
https://www.wired.com/story/heat-wave-schizophrenia/ -
In a Heat Wave, Schizophrenia Is So Much Deadlier Than Any Other Medical Condition | WIRED
https://www.wired.com/story/heat-wave-schizophrenia/ -
DATE: August 29, 2026 at 06:00AM
SOURCE: PSYPOST.ORG** Research quality varies widely from fantastic to small exploratory studies. Please check research methods when conclusions are very important to you. **
-------------------------------------------------TITLE: Genetic risk for schizophrenia and bipolar disorder is linked to specific types of intelligence
New research suggests that the genetic links between psychiatric conditions and intelligence vary depending on the specific type of thinking skill involved. Rather than viewing intelligence as a single trait, a new genetic analysis indicates that conditions like schizophrenia and bipolar disorder share different genetic roots with problem-solving skills compared to acquired knowledge. The findings were published in Nature Communications.
People diagnosed with certain psychiatric disorders often experience difficulties with memory, attention, and problem-solving. For instance, a 2023 review detailed how conditions like schizophrenia share overlapping genetic and environmental risk factors with cognitive challenges. Similarly, a study covered by PsyPost in 2024 found that higher general intelligence tends to be associated with fewer symptoms of attention-deficit hyperactivity disorder (ADHD) and autism, a connection partly driven by shared genetics.
Past genetic research generally treated cognitive ability as one broad category. However, human cognition is made up of distinct skills. These include processing speed, often measured by how fast someone reacts to a prompt. Another component is fluid reasoning, which involves solving new problems and processing complex information on the spot. A third area is crystallized knowledge, representing the facts and vocabulary a person learns through culture and life experience.
Genetic studies have historically lacked enough data to analyze these specific categories of thinking, especially crystallized knowledge. Scientists wanted to see if breaking down cognition into these specific domains might provide a more detailed picture of how mental health and intelligence are connected at a genetic level. They also wanted to account for non-cognitive skills, such as motivation and persistence, which help people succeed in educational settings.
The research was led by Diego Londoño-Correa, a PhD and recent graduate of the Department of Psychology at The University of Texas at Austin. “There was a paradox in the behavioral and psychiatric genetics literature that I found very interesting,” he said. “People diagnosed with psychiatric disorders such as schizophrenia often show cognitive difficulties, and these negative associations are observed at both the phenotypic and genetic levels. However, genetic liability for schizophrenia and some other disorders has also been positively associated with educational attainment.”
“In our lab, we wondered whether part of this apparent contradiction came from treating cognition as a single trait,” he explained. “We thought that part of the answer to this paradox might lie in the difference between these domains that previous studies had not accounted for.”
The scientists analyzed genetic data from hundreds of thousands of people. Using existing genetic databases, primarily focusing on individuals of European ancestry, they gathered information on cognitive test performance and educational attainment. The total sample size for the crystallized knowledge analysis reached roughly 439,000 individuals.
To measure specific cognitive skills, the team looked at scores from tests involving reaction time, puzzle solving, and vocabulary knowledge. “Many cognitive tests do not ‘purely’ measure a single domain such as crystallized knowledge,” Londoño-Correa explained. “For example, you still need lower-order cognitive processes such as processing speed to perform well on tests of crystallized knowledge, including vocabulary tests.”
To address this, the researchers used a specialized statistical tool to separate the overlapping genetic influences of reaction time, fluid reasoning, and crystallized knowledge. They also isolated a non-cognitive genetic factor tied to how many years of schooling a person completed, removing any genetic effects related to actual test performance.
The analysis identified 78 genetic regions associated with crystallized knowledge. Eight of these regions had never been linked to any cognitive trait in previous genetic research. The researchers also found that genes associated with fluid reasoning tend to be most active in the brain during early childhood development. In contrast, genes associated with crystallized knowledge show increased activity during adolescence and early adulthood, aligning with the idea that this type of knowledge builds up over time through education and experience.
When comparing these cognitive profiles to the genetic risk for five specific psychiatric conditions, the authors found highly varied patterns. Schizophrenia and bipolar disorder showed the most similarity. The genetic risk for both conditions was associated with slower reaction times and lower fluid reasoning, but positively associated with both crystallized knowledge and non-cognitive educational skills.
“The main takeaway is that the genetic relationship between psychiatric disorders and cognitive abilities is not uniformly positive or negative,” Londoño-Correa said. “Reducing all of cognition to a single general factor of intelligence can hide meaningful differences in how psychiatric genetic liability relates to different cognitive abilities.”
Other conditions displayed entirely different genetic associations. The genetic risk for ADHD was associated with slightly faster reaction times, but it was also linked to lower fluid reasoning, lower crystallized knowledge, and lower non-cognitive skills. Autism spectrum disorder was positively associated only with crystallized knowledge. Alzheimer’s disease was associated only with lower fluid reasoning, matching the clinical observation that dementia often heavily impacts executive functioning and on-the-spot problem-solving.
The researchers also compared the cognitive genetic factors to personality traits. They found that openness to experience, a trait linked to curiosity and a desire to learn, was strongly and positively associated with the genetics of crystallized knowledge.
Londoño-Correa found this specificity particularly striking, noting that openness had a strong correlation with crystallized knowledge but much weaker associations with reaction time and fluid reasoning. “Developmental psychologists propose these genetic tendencies as ‘experience-producing drives’ so people who are more curious may seek out books, conversations, education, cultural experiences, or other cognitively rewarding environments,” he said. “Over time those experiences accumulate into crystallized knowledge, the trait that was correlated with higher risk for schizophrenia, bipolar disorder and autism.”
These findings offer new insights, but they are subject to certain limitations. The genetic overlap between a psychiatric disorder and a cognitive trait does not mean that having a specific gene will automatically cause a mental health condition or guarantee high intelligence.
“The most important caveat is that genetic liability is not the same thing as having a psychiatric disorder,” Londoño-Correa explained. “That is very different from saying that people diagnosed with schizophrenia have higher crystallized abilities. We are studying how genetic variation can relate to multiple traits at the same time, not describing the average characteristics of diagnosed individuals.”
He emphasized that the study should not be interpreted as showing that clinical conditions like schizophrenia or autism improve cognition, as these disorders can have very serious cognitive and functional consequences. Furthermore, the study relied entirely on data from people of European descent to avoid statistical errors that can happen when mixing different genetic backgrounds, meaning the results might not apply to other ancestries.
Looking ahead, the research team hopes to use these insights to explore broader evolutionary questions. “My broader interest is in understanding why genetic variation associated with psychiatric disorders persists across human evolutionary history despite the health and reproductive costs these disorders can impose, particularly for conditions that often begin relatively early in life,” Londoño-Correa said.
He pointed to a concept known as antagonistic pleiotropy, where genetic variants that increase vulnerability to a disorder might also confer cognitive or behavioral advantages. “This study does not test natural selection directly, so we need more sophisticated analyses, for example using ancient DNA, to ask whether psychiatric-risk variants that are also associated with higher cognitive performance increased in frequency during human history,” he added.
The study, “Crystallized and fluid cognitive abilities have different genetic associations with neuropsychiatric disorders,” was authored by Diego Londono-Correa, Javier de la Fuente, Gail Davies, Simon R. Cox, Ian J. Deary, K. Paige Harden, and Elliot M. Tucker-Drob.
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #GeneticLinks #Schizophrenia #BipolarDisorder #CognitiveAbilities #CrystallizedKnowledge #FluidReasoning #ProcessingSpeed #NeuropsychiatricGenetics #EducationalAttainment #OpenToExperience
-
DATE: August 29, 2026 at 06:00AM
SOURCE: PSYPOST.ORG** Research quality varies widely from fantastic to small exploratory studies. Please check research methods when conclusions are very important to you. **
-------------------------------------------------TITLE: Genetic risk for schizophrenia and bipolar disorder is linked to specific types of intelligence
New research suggests that the genetic links between psychiatric conditions and intelligence vary depending on the specific type of thinking skill involved. Rather than viewing intelligence as a single trait, a new genetic analysis indicates that conditions like schizophrenia and bipolar disorder share different genetic roots with problem-solving skills compared to acquired knowledge. The findings were published in Nature Communications.
People diagnosed with certain psychiatric disorders often experience difficulties with memory, attention, and problem-solving. For instance, a 2023 review detailed how conditions like schizophrenia share overlapping genetic and environmental risk factors with cognitive challenges. Similarly, a study covered by PsyPost in 2024 found that higher general intelligence tends to be associated with fewer symptoms of attention-deficit hyperactivity disorder (ADHD) and autism, a connection partly driven by shared genetics.
Past genetic research generally treated cognitive ability as one broad category. However, human cognition is made up of distinct skills. These include processing speed, often measured by how fast someone reacts to a prompt. Another component is fluid reasoning, which involves solving new problems and processing complex information on the spot. A third area is crystallized knowledge, representing the facts and vocabulary a person learns through culture and life experience.
Genetic studies have historically lacked enough data to analyze these specific categories of thinking, especially crystallized knowledge. Scientists wanted to see if breaking down cognition into these specific domains might provide a more detailed picture of how mental health and intelligence are connected at a genetic level. They also wanted to account for non-cognitive skills, such as motivation and persistence, which help people succeed in educational settings.
The research was led by Diego Londoño-Correa, a PhD and recent graduate of the Department of Psychology at The University of Texas at Austin. “There was a paradox in the behavioral and psychiatric genetics literature that I found very interesting,” he said. “People diagnosed with psychiatric disorders such as schizophrenia often show cognitive difficulties, and these negative associations are observed at both the phenotypic and genetic levels. However, genetic liability for schizophrenia and some other disorders has also been positively associated with educational attainment.”
“In our lab, we wondered whether part of this apparent contradiction came from treating cognition as a single trait,” he explained. “We thought that part of the answer to this paradox might lie in the difference between these domains that previous studies had not accounted for.”
The scientists analyzed genetic data from hundreds of thousands of people. Using existing genetic databases, primarily focusing on individuals of European ancestry, they gathered information on cognitive test performance and educational attainment. The total sample size for the crystallized knowledge analysis reached roughly 439,000 individuals.
To measure specific cognitive skills, the team looked at scores from tests involving reaction time, puzzle solving, and vocabulary knowledge. “Many cognitive tests do not ‘purely’ measure a single domain such as crystallized knowledge,” Londoño-Correa explained. “For example, you still need lower-order cognitive processes such as processing speed to perform well on tests of crystallized knowledge, including vocabulary tests.”
To address this, the researchers used a specialized statistical tool to separate the overlapping genetic influences of reaction time, fluid reasoning, and crystallized knowledge. They also isolated a non-cognitive genetic factor tied to how many years of schooling a person completed, removing any genetic effects related to actual test performance.
The analysis identified 78 genetic regions associated with crystallized knowledge. Eight of these regions had never been linked to any cognitive trait in previous genetic research. The researchers also found that genes associated with fluid reasoning tend to be most active in the brain during early childhood development. In contrast, genes associated with crystallized knowledge show increased activity during adolescence and early adulthood, aligning with the idea that this type of knowledge builds up over time through education and experience.
When comparing these cognitive profiles to the genetic risk for five specific psychiatric conditions, the authors found highly varied patterns. Schizophrenia and bipolar disorder showed the most similarity. The genetic risk for both conditions was associated with slower reaction times and lower fluid reasoning, but positively associated with both crystallized knowledge and non-cognitive educational skills.
“The main takeaway is that the genetic relationship between psychiatric disorders and cognitive abilities is not uniformly positive or negative,” Londoño-Correa said. “Reducing all of cognition to a single general factor of intelligence can hide meaningful differences in how psychiatric genetic liability relates to different cognitive abilities.”
Other conditions displayed entirely different genetic associations. The genetic risk for ADHD was associated with slightly faster reaction times, but it was also linked to lower fluid reasoning, lower crystallized knowledge, and lower non-cognitive skills. Autism spectrum disorder was positively associated only with crystallized knowledge. Alzheimer’s disease was associated only with lower fluid reasoning, matching the clinical observation that dementia often heavily impacts executive functioning and on-the-spot problem-solving.
The researchers also compared the cognitive genetic factors to personality traits. They found that openness to experience, a trait linked to curiosity and a desire to learn, was strongly and positively associated with the genetics of crystallized knowledge.
Londoño-Correa found this specificity particularly striking, noting that openness had a strong correlation with crystallized knowledge but much weaker associations with reaction time and fluid reasoning. “Developmental psychologists propose these genetic tendencies as ‘experience-producing drives’ so people who are more curious may seek out books, conversations, education, cultural experiences, or other cognitively rewarding environments,” he said. “Over time those experiences accumulate into crystallized knowledge, the trait that was correlated with higher risk for schizophrenia, bipolar disorder and autism.”
These findings offer new insights, but they are subject to certain limitations. The genetic overlap between a psychiatric disorder and a cognitive trait does not mean that having a specific gene will automatically cause a mental health condition or guarantee high intelligence.
“The most important caveat is that genetic liability is not the same thing as having a psychiatric disorder,” Londoño-Correa explained. “That is very different from saying that people diagnosed with schizophrenia have higher crystallized abilities. We are studying how genetic variation can relate to multiple traits at the same time, not describing the average characteristics of diagnosed individuals.”
He emphasized that the study should not be interpreted as showing that clinical conditions like schizophrenia or autism improve cognition, as these disorders can have very serious cognitive and functional consequences. Furthermore, the study relied entirely on data from people of European descent to avoid statistical errors that can happen when mixing different genetic backgrounds, meaning the results might not apply to other ancestries.
Looking ahead, the research team hopes to use these insights to explore broader evolutionary questions. “My broader interest is in understanding why genetic variation associated with psychiatric disorders persists across human evolutionary history despite the health and reproductive costs these disorders can impose, particularly for conditions that often begin relatively early in life,” Londoño-Correa said.
He pointed to a concept known as antagonistic pleiotropy, where genetic variants that increase vulnerability to a disorder might also confer cognitive or behavioral advantages. “This study does not test natural selection directly, so we need more sophisticated analyses, for example using ancient DNA, to ask whether psychiatric-risk variants that are also associated with higher cognitive performance increased in frequency during human history,” he added.
The study, “Crystallized and fluid cognitive abilities have different genetic associations with neuropsychiatric disorders,” was authored by Diego Londono-Correa, Javier de la Fuente, Gail Davies, Simon R. Cox, Ian J. Deary, K. Paige Harden, and Elliot M. Tucker-Drob.
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #GeneticLinks #Schizophrenia #BipolarDisorder #CognitiveAbilities #CrystallizedKnowledge #FluidReasoning #ProcessingSpeed #NeuropsychiatricGenetics #EducationalAttainment #OpenToExperience
-
DATE: August 29, 2026 at 06:00AM
SOURCE: PSYPOST.ORG** Research quality varies widely from fantastic to small exploratory studies. Please check research methods when conclusions are very important to you. **
-------------------------------------------------TITLE: Genetic risk for schizophrenia and bipolar disorder is linked to specific types of intelligence
New research suggests that the genetic links between psychiatric conditions and intelligence vary depending on the specific type of thinking skill involved. Rather than viewing intelligence as a single trait, a new genetic analysis indicates that conditions like schizophrenia and bipolar disorder share different genetic roots with problem-solving skills compared to acquired knowledge. The findings were published in Nature Communications.
People diagnosed with certain psychiatric disorders often experience difficulties with memory, attention, and problem-solving. For instance, a 2023 review detailed how conditions like schizophrenia share overlapping genetic and environmental risk factors with cognitive challenges. Similarly, a study covered by PsyPost in 2024 found that higher general intelligence tends to be associated with fewer symptoms of attention-deficit hyperactivity disorder (ADHD) and autism, a connection partly driven by shared genetics.
Past genetic research generally treated cognitive ability as one broad category. However, human cognition is made up of distinct skills. These include processing speed, often measured by how fast someone reacts to a prompt. Another component is fluid reasoning, which involves solving new problems and processing complex information on the spot. A third area is crystallized knowledge, representing the facts and vocabulary a person learns through culture and life experience.
Genetic studies have historically lacked enough data to analyze these specific categories of thinking, especially crystallized knowledge. Scientists wanted to see if breaking down cognition into these specific domains might provide a more detailed picture of how mental health and intelligence are connected at a genetic level. They also wanted to account for non-cognitive skills, such as motivation and persistence, which help people succeed in educational settings.
The research was led by Diego Londoño-Correa, a PhD and recent graduate of the Department of Psychology at The University of Texas at Austin. “There was a paradox in the behavioral and psychiatric genetics literature that I found very interesting,” he said. “People diagnosed with psychiatric disorders such as schizophrenia often show cognitive difficulties, and these negative associations are observed at both the phenotypic and genetic levels. However, genetic liability for schizophrenia and some other disorders has also been positively associated with educational attainment.”
“In our lab, we wondered whether part of this apparent contradiction came from treating cognition as a single trait,” he explained. “We thought that part of the answer to this paradox might lie in the difference between these domains that previous studies had not accounted for.”
The scientists analyzed genetic data from hundreds of thousands of people. Using existing genetic databases, primarily focusing on individuals of European ancestry, they gathered information on cognitive test performance and educational attainment. The total sample size for the crystallized knowledge analysis reached roughly 439,000 individuals.
To measure specific cognitive skills, the team looked at scores from tests involving reaction time, puzzle solving, and vocabulary knowledge. “Many cognitive tests do not ‘purely’ measure a single domain such as crystallized knowledge,” Londoño-Correa explained. “For example, you still need lower-order cognitive processes such as processing speed to perform well on tests of crystallized knowledge, including vocabulary tests.”
To address this, the researchers used a specialized statistical tool to separate the overlapping genetic influences of reaction time, fluid reasoning, and crystallized knowledge. They also isolated a non-cognitive genetic factor tied to how many years of schooling a person completed, removing any genetic effects related to actual test performance.
The analysis identified 78 genetic regions associated with crystallized knowledge. Eight of these regions had never been linked to any cognitive trait in previous genetic research. The researchers also found that genes associated with fluid reasoning tend to be most active in the brain during early childhood development. In contrast, genes associated with crystallized knowledge show increased activity during adolescence and early adulthood, aligning with the idea that this type of knowledge builds up over time through education and experience.
When comparing these cognitive profiles to the genetic risk for five specific psychiatric conditions, the authors found highly varied patterns. Schizophrenia and bipolar disorder showed the most similarity. The genetic risk for both conditions was associated with slower reaction times and lower fluid reasoning, but positively associated with both crystallized knowledge and non-cognitive educational skills.
“The main takeaway is that the genetic relationship between psychiatric disorders and cognitive abilities is not uniformly positive or negative,” Londoño-Correa said. “Reducing all of cognition to a single general factor of intelligence can hide meaningful differences in how psychiatric genetic liability relates to different cognitive abilities.”
Other conditions displayed entirely different genetic associations. The genetic risk for ADHD was associated with slightly faster reaction times, but it was also linked to lower fluid reasoning, lower crystallized knowledge, and lower non-cognitive skills. Autism spectrum disorder was positively associated only with crystallized knowledge. Alzheimer’s disease was associated only with lower fluid reasoning, matching the clinical observation that dementia often heavily impacts executive functioning and on-the-spot problem-solving.
The researchers also compared the cognitive genetic factors to personality traits. They found that openness to experience, a trait linked to curiosity and a desire to learn, was strongly and positively associated with the genetics of crystallized knowledge.
Londoño-Correa found this specificity particularly striking, noting that openness had a strong correlation with crystallized knowledge but much weaker associations with reaction time and fluid reasoning. “Developmental psychologists propose these genetic tendencies as ‘experience-producing drives’ so people who are more curious may seek out books, conversations, education, cultural experiences, or other cognitively rewarding environments,” he said. “Over time those experiences accumulate into crystallized knowledge, the trait that was correlated with higher risk for schizophrenia, bipolar disorder and autism.”
These findings offer new insights, but they are subject to certain limitations. The genetic overlap between a psychiatric disorder and a cognitive trait does not mean that having a specific gene will automatically cause a mental health condition or guarantee high intelligence.
“The most important caveat is that genetic liability is not the same thing as having a psychiatric disorder,” Londoño-Correa explained. “That is very different from saying that people diagnosed with schizophrenia have higher crystallized abilities. We are studying how genetic variation can relate to multiple traits at the same time, not describing the average characteristics of diagnosed individuals.”
He emphasized that the study should not be interpreted as showing that clinical conditions like schizophrenia or autism improve cognition, as these disorders can have very serious cognitive and functional consequences. Furthermore, the study relied entirely on data from people of European descent to avoid statistical errors that can happen when mixing different genetic backgrounds, meaning the results might not apply to other ancestries.
Looking ahead, the research team hopes to use these insights to explore broader evolutionary questions. “My broader interest is in understanding why genetic variation associated with psychiatric disorders persists across human evolutionary history despite the health and reproductive costs these disorders can impose, particularly for conditions that often begin relatively early in life,” Londoño-Correa said.
He pointed to a concept known as antagonistic pleiotropy, where genetic variants that increase vulnerability to a disorder might also confer cognitive or behavioral advantages. “This study does not test natural selection directly, so we need more sophisticated analyses, for example using ancient DNA, to ask whether psychiatric-risk variants that are also associated with higher cognitive performance increased in frequency during human history,” he added.
The study, “Crystallized and fluid cognitive abilities have different genetic associations with neuropsychiatric disorders,” was authored by Diego Londono-Correa, Javier de la Fuente, Gail Davies, Simon R. Cox, Ian J. Deary, K. Paige Harden, and Elliot M. Tucker-Drob.
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #GeneticLinks #Schizophrenia #BipolarDisorder #CognitiveAbilities #CrystallizedKnowledge #FluidReasoning #ProcessingSpeed #NeuropsychiatricGenetics #EducationalAttainment #OpenToExperience
-
DATE: August 29, 2026 at 06:00AM
SOURCE: PSYPOST.ORG** Research quality varies widely from fantastic to small exploratory studies. Please check research methods when conclusions are very important to you. **
-------------------------------------------------TITLE: Genetic risk for schizophrenia and bipolar disorder is linked to specific types of intelligence
New research suggests that the genetic links between psychiatric conditions and intelligence vary depending on the specific type of thinking skill involved. Rather than viewing intelligence as a single trait, a new genetic analysis indicates that conditions like schizophrenia and bipolar disorder share different genetic roots with problem-solving skills compared to acquired knowledge. The findings were published in Nature Communications.
People diagnosed with certain psychiatric disorders often experience difficulties with memory, attention, and problem-solving. For instance, a 2023 review detailed how conditions like schizophrenia share overlapping genetic and environmental risk factors with cognitive challenges. Similarly, a study covered by PsyPost in 2024 found that higher general intelligence tends to be associated with fewer symptoms of attention-deficit hyperactivity disorder (ADHD) and autism, a connection partly driven by shared genetics.
Past genetic research generally treated cognitive ability as one broad category. However, human cognition is made up of distinct skills. These include processing speed, often measured by how fast someone reacts to a prompt. Another component is fluid reasoning, which involves solving new problems and processing complex information on the spot. A third area is crystallized knowledge, representing the facts and vocabulary a person learns through culture and life experience.
Genetic studies have historically lacked enough data to analyze these specific categories of thinking, especially crystallized knowledge. Scientists wanted to see if breaking down cognition into these specific domains might provide a more detailed picture of how mental health and intelligence are connected at a genetic level. They also wanted to account for non-cognitive skills, such as motivation and persistence, which help people succeed in educational settings.
The research was led by Diego Londoño-Correa, a PhD and recent graduate of the Department of Psychology at The University of Texas at Austin. “There was a paradox in the behavioral and psychiatric genetics literature that I found very interesting,” he said. “People diagnosed with psychiatric disorders such as schizophrenia often show cognitive difficulties, and these negative associations are observed at both the phenotypic and genetic levels. However, genetic liability for schizophrenia and some other disorders has also been positively associated with educational attainment.”
“In our lab, we wondered whether part of this apparent contradiction came from treating cognition as a single trait,” he explained. “We thought that part of the answer to this paradox might lie in the difference between these domains that previous studies had not accounted for.”
The scientists analyzed genetic data from hundreds of thousands of people. Using existing genetic databases, primarily focusing on individuals of European ancestry, they gathered information on cognitive test performance and educational attainment. The total sample size for the crystallized knowledge analysis reached roughly 439,000 individuals.
To measure specific cognitive skills, the team looked at scores from tests involving reaction time, puzzle solving, and vocabulary knowledge. “Many cognitive tests do not ‘purely’ measure a single domain such as crystallized knowledge,” Londoño-Correa explained. “For example, you still need lower-order cognitive processes such as processing speed to perform well on tests of crystallized knowledge, including vocabulary tests.”
To address this, the researchers used a specialized statistical tool to separate the overlapping genetic influences of reaction time, fluid reasoning, and crystallized knowledge. They also isolated a non-cognitive genetic factor tied to how many years of schooling a person completed, removing any genetic effects related to actual test performance.
The analysis identified 78 genetic regions associated with crystallized knowledge. Eight of these regions had never been linked to any cognitive trait in previous genetic research. The researchers also found that genes associated with fluid reasoning tend to be most active in the brain during early childhood development. In contrast, genes associated with crystallized knowledge show increased activity during adolescence and early adulthood, aligning with the idea that this type of knowledge builds up over time through education and experience.
When comparing these cognitive profiles to the genetic risk for five specific psychiatric conditions, the authors found highly varied patterns. Schizophrenia and bipolar disorder showed the most similarity. The genetic risk for both conditions was associated with slower reaction times and lower fluid reasoning, but positively associated with both crystallized knowledge and non-cognitive educational skills.
“The main takeaway is that the genetic relationship between psychiatric disorders and cognitive abilities is not uniformly positive or negative,” Londoño-Correa said. “Reducing all of cognition to a single general factor of intelligence can hide meaningful differences in how psychiatric genetic liability relates to different cognitive abilities.”
Other conditions displayed entirely different genetic associations. The genetic risk for ADHD was associated with slightly faster reaction times, but it was also linked to lower fluid reasoning, lower crystallized knowledge, and lower non-cognitive skills. Autism spectrum disorder was positively associated only with crystallized knowledge. Alzheimer’s disease was associated only with lower fluid reasoning, matching the clinical observation that dementia often heavily impacts executive functioning and on-the-spot problem-solving.
The researchers also compared the cognitive genetic factors to personality traits. They found that openness to experience, a trait linked to curiosity and a desire to learn, was strongly and positively associated with the genetics of crystallized knowledge.
Londoño-Correa found this specificity particularly striking, noting that openness had a strong correlation with crystallized knowledge but much weaker associations with reaction time and fluid reasoning. “Developmental psychologists propose these genetic tendencies as ‘experience-producing drives’ so people who are more curious may seek out books, conversations, education, cultural experiences, or other cognitively rewarding environments,” he said. “Over time those experiences accumulate into crystallized knowledge, the trait that was correlated with higher risk for schizophrenia, bipolar disorder and autism.”
These findings offer new insights, but they are subject to certain limitations. The genetic overlap between a psychiatric disorder and a cognitive trait does not mean that having a specific gene will automatically cause a mental health condition or guarantee high intelligence.
“The most important caveat is that genetic liability is not the same thing as having a psychiatric disorder,” Londoño-Correa explained. “That is very different from saying that people diagnosed with schizophrenia have higher crystallized abilities. We are studying how genetic variation can relate to multiple traits at the same time, not describing the average characteristics of diagnosed individuals.”
He emphasized that the study should not be interpreted as showing that clinical conditions like schizophrenia or autism improve cognition, as these disorders can have very serious cognitive and functional consequences. Furthermore, the study relied entirely on data from people of European descent to avoid statistical errors that can happen when mixing different genetic backgrounds, meaning the results might not apply to other ancestries.
Looking ahead, the research team hopes to use these insights to explore broader evolutionary questions. “My broader interest is in understanding why genetic variation associated with psychiatric disorders persists across human evolutionary history despite the health and reproductive costs these disorders can impose, particularly for conditions that often begin relatively early in life,” Londoño-Correa said.
He pointed to a concept known as antagonistic pleiotropy, where genetic variants that increase vulnerability to a disorder might also confer cognitive or behavioral advantages. “This study does not test natural selection directly, so we need more sophisticated analyses, for example using ancient DNA, to ask whether psychiatric-risk variants that are also associated with higher cognitive performance increased in frequency during human history,” he added.
The study, “Crystallized and fluid cognitive abilities have different genetic associations with neuropsychiatric disorders,” was authored by Diego Londono-Correa, Javier de la Fuente, Gail Davies, Simon R. Cox, Ian J. Deary, K. Paige Harden, and Elliot M. Tucker-Drob.
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #GeneticLinks #Schizophrenia #BipolarDisorder #CognitiveAbilities #CrystallizedKnowledge #FluidReasoning #ProcessingSpeed #NeuropsychiatricGenetics #EducationalAttainment #OpenToExperience
-
https://www.europesays.com/ie/655830/ Study finds distinct patterns of innate immune activity in mental disorders #Bacterial #BipolarDisorder #blood #Brain #Depression #Éire #Health #IE #ImmuneResponse #ImmuneSystem #immunity #Ireland #MentalHealth #Psychiatry #Receptor #Research #RNA #Schizophrenia #Stress
-
DATE: August 20, 2026 at 07:27AM
SOURCE: SCIENCE DAILY PSYCHIATIRY FEEDTITLE: Schizophrenia’s lost brain connections follow a surprising pattern
URL: https://www.sciencedaily.com/releases/2026/08/260820002443.htm
Specialized brain scans reveal that schizophrenia is linked to widespread loss of the synapses that connect brain cells, with the left side of the brain hit especially hard. The damage follows a surprisingly organized pattern tied to the brain’s chemistry and wiring. Researchers also identified a left frontal region that may serve as a starting point for the loss.
URL: https://www.sciencedaily.com/releases/2026/08/260820002443.htm
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #Schizophrenia #BrainScience #Neuroscience #SynapseLoss #LeftBrain #FrontalLobe #BrainChemistry #NeuralConnections #MentalHealthResearch #NeuroscienceNews
-
DATE: August 20, 2026 at 07:27AM
SOURCE: SCIENCE DAILY PSYCHIATIRY FEEDTITLE: Schizophrenia’s lost brain connections follow a surprising pattern
URL: https://www.sciencedaily.com/releases/2026/08/260820002443.htm
Specialized brain scans reveal that schizophrenia is linked to widespread loss of the synapses that connect brain cells, with the left side of the brain hit especially hard. The damage follows a surprisingly organized pattern tied to the brain’s chemistry and wiring. Researchers also identified a left frontal region that may serve as a starting point for the loss.
URL: https://www.sciencedaily.com/releases/2026/08/260820002443.htm
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #Schizophrenia #BrainScience #Neuroscience #SynapseLoss #LeftBrain #FrontalLobe #BrainChemistry #NeuralConnections #MentalHealthResearch #NeuroscienceNews
-
DATE: August 20, 2026 at 07:27AM
SOURCE: SCIENCE DAILY PSYCHIATIRY FEEDTITLE: Schizophrenia’s lost brain connections follow a surprising pattern
URL: https://www.sciencedaily.com/releases/2026/08/260820002443.htm
Specialized brain scans reveal that schizophrenia is linked to widespread loss of the synapses that connect brain cells, with the left side of the brain hit especially hard. The damage follows a surprisingly organized pattern tied to the brain’s chemistry and wiring. Researchers also identified a left frontal region that may serve as a starting point for the loss.
URL: https://www.sciencedaily.com/releases/2026/08/260820002443.htm
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #Schizophrenia #BrainScience #Neuroscience #SynapseLoss #LeftBrain #FrontalLobe #BrainChemistry #NeuralConnections #MentalHealthResearch #NeuroscienceNews
-
DATE: August 20, 2026 at 07:27AM
SOURCE: SCIENCE DAILY PSYCHOLOGY FEEDTITLE: Schizophrenia’s lost brain connections follow a surprising pattern
URL: https://www.sciencedaily.com/releases/2026/08/260820002443.htm
Specialized brain scans reveal that schizophrenia is linked to widespread loss of the synapses that connect brain cells, with the left side of the brain hit especially hard. The damage follows a surprisingly organized pattern tied to the brain’s chemistry and wiring. Researchers also identified a left frontal region that may serve as a starting point for the loss.
URL: https://www.sciencedaily.com/releases/2026/08/260820002443.htm
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #Schizophrenia #BrainScience #Neuroscience #SynapseLoss #LeftBrain #FrontalLobe #MentalHealthResearch #NeuralConnectivity #BrainPatterns #ScienceNews
-
DATE: August 20, 2026 at 07:27AM
SOURCE: SCIENCE DAILY PSYCHOLOGY FEEDTITLE: Schizophrenia’s lost brain connections follow a surprising pattern
URL: https://www.sciencedaily.com/releases/2026/08/260820002443.htm
Specialized brain scans reveal that schizophrenia is linked to widespread loss of the synapses that connect brain cells, with the left side of the brain hit especially hard. The damage follows a surprisingly organized pattern tied to the brain’s chemistry and wiring. Researchers also identified a left frontal region that may serve as a starting point for the loss.
URL: https://www.sciencedaily.com/releases/2026/08/260820002443.htm
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #Schizophrenia #BrainScience #Neuroscience #SynapseLoss #LeftBrain #FrontalLobe #MentalHealthResearch #NeuralConnectivity #BrainPatterns #ScienceNews
-
DATE: August 20, 2026 at 07:27AM
SOURCE: SCIENCE DAILY PSYCHOLOGY FEEDTITLE: Schizophrenia’s lost brain connections follow a surprising pattern
URL: https://www.sciencedaily.com/releases/2026/08/260820002443.htm
Specialized brain scans reveal that schizophrenia is linked to widespread loss of the synapses that connect brain cells, with the left side of the brain hit especially hard. The damage follows a surprisingly organized pattern tied to the brain’s chemistry and wiring. Researchers also identified a left frontal region that may serve as a starting point for the loss.
URL: https://www.sciencedaily.com/releases/2026/08/260820002443.htm
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #Schizophrenia #BrainScience #Neuroscience #SynapseLoss #LeftBrain #FrontalLobe #MentalHealthResearch #NeuralConnectivity #BrainPatterns #ScienceNews
-
DATE: August 20, 2026 at 07:27AM
SOURCE: SCIENCE DAILY MIND-BRAIN FEEDTITLE: Schizophrenia’s lost brain connections follow a surprising pattern
URL: https://www.sciencedaily.com/releases/2026/08/260820002443.htm
Specialized brain scans reveal that schizophrenia is linked to widespread loss of the synapses that connect brain cells, with the left side of the brain hit especially hard. The damage follows a surprisingly organized pattern tied to the brain’s chemistry and wiring. Researchers also identified a left frontal region that may serve as a starting point for the loss.
URL: https://www.sciencedaily.com/releases/2026/08/260820002443.htm
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #Schizophrenia #BrainConnections #SynapseLoss #LeftBrain #LeftFrontalLobe #Neuroscience #MentalHealthResearch #BrainChemistry #NeuralWiring #NeurologyInsights
-
DATE: August 20, 2026 at 07:27AM
SOURCE: SCIENCE DAILY MIND-BRAIN FEEDTITLE: Schizophrenia’s lost brain connections follow a surprising pattern
URL: https://www.sciencedaily.com/releases/2026/08/260820002443.htm
Specialized brain scans reveal that schizophrenia is linked to widespread loss of the synapses that connect brain cells, with the left side of the brain hit especially hard. The damage follows a surprisingly organized pattern tied to the brain’s chemistry and wiring. Researchers also identified a left frontal region that may serve as a starting point for the loss.
URL: https://www.sciencedaily.com/releases/2026/08/260820002443.htm
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #Schizophrenia #BrainConnections #SynapseLoss #LeftBrain #LeftFrontalLobe #Neuroscience #MentalHealthResearch #BrainChemistry #NeuralWiring #NeurologyInsights
-
DATE: August 20, 2026 at 07:27AM
SOURCE: SCIENCE DAILY MIND-BRAIN FEEDTITLE: Schizophrenia’s lost brain connections follow a surprising pattern
URL: https://www.sciencedaily.com/releases/2026/08/260820002443.htm
Specialized brain scans reveal that schizophrenia is linked to widespread loss of the synapses that connect brain cells, with the left side of the brain hit especially hard. The damage follows a surprisingly organized pattern tied to the brain’s chemistry and wiring. Researchers also identified a left frontal region that may serve as a starting point for the loss.
URL: https://www.sciencedaily.com/releases/2026/08/260820002443.htm
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #Schizophrenia #BrainConnections #SynapseLoss #LeftBrain #LeftFrontalLobe #Neuroscience #MentalHealthResearch #BrainChemistry #NeuralWiring #NeurologyInsights
-
https://www.europesays.com/ie/644732/ Severe mental illness may accelerate dementia and stroke vulnerability #BipolarDisorder #Brain #dementia #Depression #Éire #Health #HealthCare #Healthcare #hospital #IE #Ireland #IschemicStroke #MentalHealth #Neuropsychopharmacology #Research #Schizophrenia #Stroke
-
In a heat wave, one health condition causes much higher mortality than others: #schizophrenia.
#Vancouver’s St. Paul’s hospital ER was a clue to the research finding.
-
In a heat wave, one health condition causes much higher mortality than others: #schizophrenia.
#Vancouver’s St. Paul’s hospital ER was a clue to the research finding.
-
In a heat wave, one health condition causes much higher mortality than others: #schizophrenia.
#Vancouver’s St. Paul’s hospital ER was a clue to the research finding.
-
In a heat wave, one health condition causes much higher mortality than others: #schizophrenia.
#Vancouver’s St. Paul’s hospital ER was a clue to the research finding.
-
In a heat wave, one health condition causes much higher mortality than others: #schizophrenia.
#Vancouver’s St. Paul’s hospital ER was a clue to the research finding.
-
-
https://www.europesays.com/ie/635575/ Subtle brain differences detected in children at risk for schizophrenia #Adolescents #Brain #children #Éire #GreyMatter #Health #IE #Ireland #Schizophrenia
-
AI Is Helping Solve the Intricate Genetic Puzzle of Schizophrenia
One of the greatest challenges in modern genetics is schizophrenia. Unlike diseases caused by a single mutation, this…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Mentalhealth #Artificialintelligence #brains #cognitivescience #Genetics #Health #MentalHealth #schizophrenia
https://www.newsbeep.com/us/810122/ -
AI Is Helping Solve the Intricate Genetic Puzzle of Schizophrenia
One of the greatest challenges in modern genetics is schizophrenia. Unlike diseases caused by a single mutation, this…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Mentalhealth #Artificialintelligence #brains #cognitivescience #Genetics #Health #MentalHealth #schizophrenia
https://www.newsbeep.com/us/810122/ -
https://www.europesays.com/uk/1142961/ AI Is Helping Solve the Intricate Genetic Puzzle of Schizophrenia #ArtificialIntelligence #brains #CognitiveScience #Genetics #Health #MentalHealth #schizophrenia #UK #UnitedKingdom
-
AI Is Helping Solve the Intricate Genetic Puzzle of Schizophrenia
One of the greatest challenges in modern genetics is schizophrenia. Unlike diseases caused by a single mutation, this…
#NewsBeep #News #Mentalhealth #ArtificialIntelligence #brains #cognitivescience #Genetics #Health #MentalHealth #schizophrenia #UK #UnitedKingdom
https://www.newsbeep.com/uk/734476/ -
AI Is Helping Solve the Intricate Genetic Puzzle of Schizophrenia
-
AI Is Helping Solve the Intricate Genetic Puzzle of Schizophrenia
-
AI Is Helping Solve the Intricate Genetic Puzzle of Schizophrenia
-
AI Is Helping Solve the Intricate Genetic Puzzle of Schizophrenia
-
AI Is Helping Solve the Intricate Genetic Puzzle of Schizophrenia
-
https://www.europesays.com/be-nl/119635/ Municipal Waste – Dynamo Eindhoven – 10/08/2026 #BE #België #Belgium #DynamoEindhoven #MunicipalWaste #schizophrenia #Science #ScienceAndTechnology #ScienceAndTechnology #Technologie #Technology #Wetenschap #WetenschapEnTechnologie #WetenschapTechnologie
-
A Scanner Darkly: Trailer for the 2006 Linklater film of PK Dick's fascinating book. The movie is really special and worth a watch.
https://www.youtube.com/watch?v=hkjDUERgCQw
#schizophrenia #rotoscope #movies #pkdick #scifi #dick #+ -
A Scanner Darkly: Trailer for the 2006 Linklater film of PK Dick's fascinating book. The movie is really special and worth a watch.
https://www.youtube.com/watch?v=hkjDUERgCQw
#schizophrenia #rotoscope #movies #pkdick #scifi #dick #+ -
A Scanner Darkly: Trailer for the 2006 Linklater film of PK Dick's fascinating book. The movie is really special and worth a watch.
https://www.youtube.com/watch?v=hkjDUERgCQw
#schizophrenia #rotoscope #movies #pkdick #scifi #dick #+ -
A Scanner Darkly: Trailer for the 2006 Linklater film of PK Dick's fascinating book. The movie is really special and worth a watch.
https://www.youtube.com/watch?v=hkjDUERgCQw
#schizophrenia #rotoscope #movies #pkdick #scifi #dick #+ -
Психиатрия | Psychiatry | Психіатрія
#психология, #психопатология, #шизофрения, #медицина, #психологія, #психопатологія, #шизофренія, #медицина, #psychology, #psychopathology, #schizophrenia, #medicine #Психиатрия | #Psychiatry | #Психіатрія #книги #books -
Психиатрия | Psychiatry | Психіатрія
#психология, #психопатология, #шизофрения, #медицина, #психологія, #психопатологія, #шизофренія, #медицина, #psychology, #psychopathology, #schizophrenia, #medicine #Психиатрия | #Psychiatry | #Психіатрія #книги #books -
DATE: August 8, 2026 at 08:00AM
SOURCE: PSYPOST.ORG** Research quality varies widely from fantastic to small exploratory studies. Please check research methods when conclusions are very important to you. **
-------------------------------------------------TITLE: Ketogenic diet improves metabolic health and may reduce symptoms in schizophrenia and bipolar disorder
A recent study published in the Schizophrenia Bulletin suggests that a ketogenic diet provides metabolic and psychiatric benefits for individuals diagnosed with schizophrenia or bipolar disorder. The research indicates that shifting the brain’s primary fuel source from carbohydrates to fat derivatives called ketones tends to improve markers of blood sugar regulation. The findings also provide evidence that adopting this diet is associated with reduced symptoms of depression and psychosis over time.
People diagnosed with psychotic disorders frequently experience impaired cognitive function and disrupted daily living. The psychiatric medications typically prescribed to manage these conditions tend to induce high rates of metabolic dysfunction. These physical side effects often include elevated blood sugar, weight gain, and an increased risk of developing metabolic syndrome.
Metabolic syndrome involves a cluster of risk factors, such as high blood pressure and elevated fasting glucose, which correlate with shorter lifespans and more severe psychiatric symptoms. Diet plays a large role in the onset of this syndrome, and individuals with schizophrenia often face lifestyle challenges that make traditional nutritional management difficult.
The ketogenic diet is a nutritional approach composed of roughly 70 percent fat, 20 percent protein, and 10 percent carbohydrates. By severely restricting carbohydrate intake, the diet forces the body to break down fat into molecules known as ketone bodies. These ketone bodies provide an alternative energy source for cells.
Laboratory studies suggest that ketone metabolism yields more energy than glucose metabolism, which might help counteract the dysfunctional glucose processing often observed in the brains of individuals with schizophrenia. Previous case reports and uncontrolled studies provide evidence that the ketogenic diet can alleviate metabolic syndrome and psychiatric symptoms in various mental health conditions.
“A number of pilot studies have signaled the promise of a ketogenic diet as a treatment of serious mental health, but to attribute these positive effects to the diet rather than any other factors we still need randomized controlled trials (RCTs) comparing the ketogenic diet to another diet,” said Judith M. Ford, a professor in the Department of Psychiatry and Behavioral Sciences at the University of California, San Francisco. “Our study was a first attempt to directly make this comparison in participants with schizophrenia-spectrum or bipolar-1 disorder.”
The researchers recruited adult participants who met the diagnostic criteria for schizophrenia, schizoaffective disorder, or bipolar disorder with psychotic features. The research began with 58 participants who were randomly assigned to either a ketogenic diet group or a diet-as-usual control group for a one-month period.
Participants in the ketogenic diet group received 18 microwavable meals each week from a contracted delivery service. They were instructed to consume at least two provided meals a day and keep their overall carbohydrate intake below 10 percent. The diet-as-usual group was asked to continue their typical eating habits and did not receive prepared meals. Both groups received weekly check-in calls from a licensed dietitian.
The researchers measured several physiological variables, including body weight, insulin resistance, and hemoglobin A1c, which is a protein that reflects average blood sugar levels over several months. The authors also measured cognitive performance and psychiatric symptoms, such as depression and the positive and negative symptoms of psychosis. The analytical models adjusted for participants’ initial baseline scores to ensure that any observed changes were not due to preexisting differences between the groups.
At the end of the one-month trial, individuals in the ketogenic diet group demonstrated metabolic improvements compared to those eating their usual diet. Based on objective blood tests, the ketogenic group successfully reached and maintained standard nutritional ketosis. “We also showed that this diet is highly feasible in this population, with 83 percent of daily-tested participants maintaining ketosis in the one-month RCT portion of the study,” Ford noted.
Compared to the diet-as-usual group, participants on the ketogenic diet experienced a relative decrease in body mass index and lower levels of both hemoglobin A1c and insulin resistance. For instance, the ketogenic diet participants saw a moderate absolute reduction in their body weight and blood sugar markers, whereas the control group experienced nearly no change. Cognitive performance and symptoms of psychosis did not differ between the two groups at the end of the first month.
Partway through the trial, the researchers secured funding to offer an extended four-month ketogenic diet phase to all participants. A total of 25 individuals completed this extended dietary protocol. “Adherence to the diet was also high in this extension period (94 percent), with no reports of significant side effects from the diet,” Ford explained.
“I don’t know if this surprised us, but we were really encouraged to see the high feasibility of this diet in an outpatient population of patients with schizophrenia-spectrum or bipolar-1 disorder,” Ford said. “A common assumption we hear is that the diet must be too difficult for participants with severe mental illness to adhere to, but 25 of the participants opted to continue on the diet beyond the one-month RCT.”
This level of adherence suggests that lifestyle interventions are possible for this population when adequate resources are provided. “This choice to extend demonstrates the viability of this diet as a long-term intervention, along with support from our team, which included providing them with 18 microwavable ketogenic meals per week via a specialized delivery service, an initial coaching session, and support from a dietitian or research assistant,” Ford added.
Because there was no active control group for this extension phase, the researchers assessed changes by comparing the participants’ metabolic and psychiatric measurements at the four-month mark directly against their initial baseline scores. “The most notable effects in this study were the significant metabolic improvements in the ketogenic diet group compared with the control group in the RCT part of the trial,” Ford said.
After four months on the ketogenic diet, participants demonstrated enhanced cognitive performance and reductions in both the positive and negative symptoms of schizophrenia. They also experienced a marked reduction in depressive symptoms. Measurements of body mass index and hemoglobin A1c remained lower than their initial baseline levels.
“While we also saw significant improvements in depression, schizophrenia symptoms, and cognitive performance after four months on the ketogenic diet, we can’t attribute those effects to the specific diet, as it was offered to all participants at this stage,” Ford cautioned.
Readers might wonder why cognitive benefits did not appear earlier in the trial. Ford clarified this timeline, referencing similar clinical observations from other recent diet studies. “We weren’t able to see neuropsychiatric or cognitive benefits of the ketogenic diet after only one month on the diet, indicating that participants may need a longer time on the ketogenic diet for those benefits to emerge,” Ford said. “This is consistent with other similarly-sized single-arm pilot studies such as Volek et al. (2025), Campbell et al. (2025), and Sethi et al. (2024).”
To explore the mechanics behind these improvements, the authors conducted statistical tests to see if the clinical gains were tied to the presence of ketones or simply to weight loss. They found that higher levels of blood ketones strongly correlated with greater reductions in hemoglobin A1c and depressive symptoms.
Changes in body weight did not correlate with these specific metabolic or psychiatric improvements. “Also, we wondered throughout the trial if benefits would be due solely to weight loss,” Ford said. “We were gratified to find that the improvement in depressive symptoms and metabolic health was not related to weight loss but to ketone levels, even in the one-month RCT.”
The study design involves a few elements that could influence how the outcomes are interpreted. “There are a couple of caveats,” Ford noted. “First, it’s important to note that we did not have a control group for the four-month extension of the study, meaning all significant improvements we observed in neuropsychiatric symptoms and cognition were in a single-arm design. This indicates the need for longer-term RCTs to explore these effects.”
Because the control group did not receive catered meals, the ketogenic diet group had an inherent advantage in accessing free, easily prepared food that included fresh vegetables and proteins. “Second, we only provided meals to the ketogenic diet group, while the diet-as-usual group followed their regular diet,” Ford said. “As a result, we can’t rule out that meal provision itself contributed to some of the observed benefits. We recommend that future studies address this variable in their design.”
The study relied on a relatively small sample size, which prevented the authors from testing complex statistical models or separating the outcomes by specific psychiatric diagnoses. Certain physiological measurements were not tracked during the trial. The blood tests did not assess markers like cholesterol or detailed electrolyte balances.
These omitted measures are important for evaluating long-term cardiovascular health and the risk of developing kidney stones on a high-fat diet. The research team also did not track adjustments to participants’ psychiatric medications throughout the study.
Future research could benefit from longer monitoring periods and larger sample sizes to clarify how dietary interventions interact with standard psychiatric treatments.
“Our results are really promising, indicating that a ketogenic diet is feasible and safe in patients with serious mental illness, and our single-arm extension findings also indicate that the ketogenic diet may be beneficial for alleviating depression and schizophrenia symptoms,” Ford concluded. “We hope to see more funding being made available for RCTs that follow larger groups of patients for longer periods of time to establish whether the ketogenic diet is an effective treatment strategy for serious mental illness.”
The study, “Metabolic Improvements with a Ketogenic Diet Correlate with Symptom Improvement in Psychosis: A Randomized Controlled Trial,” was authored by Samantha V. Abram, Juliette M. Kyner, An Vu, Zanib Naeem, Shebani Sethi, Michael S. Jacob, Susanna L. Fryer, Daniel H. Mathalon, and Judith M. Ford.
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #KetogenicDiet #MetabolicHealth #Psychosis #Schizophrenia #BipolarDisorder #Ketones #DepressionSymptoms #MentalHealthDiet #Neuropsychiatry #SchizophreniaBullets
-
DATE: August 8, 2026 at 08:00AM
SOURCE: PSYPOST.ORG** Research quality varies widely from fantastic to small exploratory studies. Please check research methods when conclusions are very important to you. **
-------------------------------------------------TITLE: Ketogenic diet improves metabolic health and may reduce symptoms in schizophrenia and bipolar disorder
A recent study published in the Schizophrenia Bulletin suggests that a ketogenic diet provides metabolic and psychiatric benefits for individuals diagnosed with schizophrenia or bipolar disorder. The research indicates that shifting the brain’s primary fuel source from carbohydrates to fat derivatives called ketones tends to improve markers of blood sugar regulation. The findings also provide evidence that adopting this diet is associated with reduced symptoms of depression and psychosis over time.
People diagnosed with psychotic disorders frequently experience impaired cognitive function and disrupted daily living. The psychiatric medications typically prescribed to manage these conditions tend to induce high rates of metabolic dysfunction. These physical side effects often include elevated blood sugar, weight gain, and an increased risk of developing metabolic syndrome.
Metabolic syndrome involves a cluster of risk factors, such as high blood pressure and elevated fasting glucose, which correlate with shorter lifespans and more severe psychiatric symptoms. Diet plays a large role in the onset of this syndrome, and individuals with schizophrenia often face lifestyle challenges that make traditional nutritional management difficult.
The ketogenic diet is a nutritional approach composed of roughly 70 percent fat, 20 percent protein, and 10 percent carbohydrates. By severely restricting carbohydrate intake, the diet forces the body to break down fat into molecules known as ketone bodies. These ketone bodies provide an alternative energy source for cells.
Laboratory studies suggest that ketone metabolism yields more energy than glucose metabolism, which might help counteract the dysfunctional glucose processing often observed in the brains of individuals with schizophrenia. Previous case reports and uncontrolled studies provide evidence that the ketogenic diet can alleviate metabolic syndrome and psychiatric symptoms in various mental health conditions.
“A number of pilot studies have signaled the promise of a ketogenic diet as a treatment of serious mental health, but to attribute these positive effects to the diet rather than any other factors we still need randomized controlled trials (RCTs) comparing the ketogenic diet to another diet,” said Judith M. Ford, a professor in the Department of Psychiatry and Behavioral Sciences at the University of California, San Francisco. “Our study was a first attempt to directly make this comparison in participants with schizophrenia-spectrum or bipolar-1 disorder.”
The researchers recruited adult participants who met the diagnostic criteria for schizophrenia, schizoaffective disorder, or bipolar disorder with psychotic features. The research began with 58 participants who were randomly assigned to either a ketogenic diet group or a diet-as-usual control group for a one-month period.
Participants in the ketogenic diet group received 18 microwavable meals each week from a contracted delivery service. They were instructed to consume at least two provided meals a day and keep their overall carbohydrate intake below 10 percent. The diet-as-usual group was asked to continue their typical eating habits and did not receive prepared meals. Both groups received weekly check-in calls from a licensed dietitian.
The researchers measured several physiological variables, including body weight, insulin resistance, and hemoglobin A1c, which is a protein that reflects average blood sugar levels over several months. The authors also measured cognitive performance and psychiatric symptoms, such as depression and the positive and negative symptoms of psychosis. The analytical models adjusted for participants’ initial baseline scores to ensure that any observed changes were not due to preexisting differences between the groups.
At the end of the one-month trial, individuals in the ketogenic diet group demonstrated metabolic improvements compared to those eating their usual diet. Based on objective blood tests, the ketogenic group successfully reached and maintained standard nutritional ketosis. “We also showed that this diet is highly feasible in this population, with 83 percent of daily-tested participants maintaining ketosis in the one-month RCT portion of the study,” Ford noted.
Compared to the diet-as-usual group, participants on the ketogenic diet experienced a relative decrease in body mass index and lower levels of both hemoglobin A1c and insulin resistance. For instance, the ketogenic diet participants saw a moderate absolute reduction in their body weight and blood sugar markers, whereas the control group experienced nearly no change. Cognitive performance and symptoms of psychosis did not differ between the two groups at the end of the first month.
Partway through the trial, the researchers secured funding to offer an extended four-month ketogenic diet phase to all participants. A total of 25 individuals completed this extended dietary protocol. “Adherence to the diet was also high in this extension period (94 percent), with no reports of significant side effects from the diet,” Ford explained.
“I don’t know if this surprised us, but we were really encouraged to see the high feasibility of this diet in an outpatient population of patients with schizophrenia-spectrum or bipolar-1 disorder,” Ford said. “A common assumption we hear is that the diet must be too difficult for participants with severe mental illness to adhere to, but 25 of the participants opted to continue on the diet beyond the one-month RCT.”
This level of adherence suggests that lifestyle interventions are possible for this population when adequate resources are provided. “This choice to extend demonstrates the viability of this diet as a long-term intervention, along with support from our team, which included providing them with 18 microwavable ketogenic meals per week via a specialized delivery service, an initial coaching session, and support from a dietitian or research assistant,” Ford added.
Because there was no active control group for this extension phase, the researchers assessed changes by comparing the participants’ metabolic and psychiatric measurements at the four-month mark directly against their initial baseline scores. “The most notable effects in this study were the significant metabolic improvements in the ketogenic diet group compared with the control group in the RCT part of the trial,” Ford said.
After four months on the ketogenic diet, participants demonstrated enhanced cognitive performance and reductions in both the positive and negative symptoms of schizophrenia. They also experienced a marked reduction in depressive symptoms. Measurements of body mass index and hemoglobin A1c remained lower than their initial baseline levels.
“While we also saw significant improvements in depression, schizophrenia symptoms, and cognitive performance after four months on the ketogenic diet, we can’t attribute those effects to the specific diet, as it was offered to all participants at this stage,” Ford cautioned.
Readers might wonder why cognitive benefits did not appear earlier in the trial. Ford clarified this timeline, referencing similar clinical observations from other recent diet studies. “We weren’t able to see neuropsychiatric or cognitive benefits of the ketogenic diet after only one month on the diet, indicating that participants may need a longer time on the ketogenic diet for those benefits to emerge,” Ford said. “This is consistent with other similarly-sized single-arm pilot studies such as Volek et al. (2025), Campbell et al. (2025), and Sethi et al. (2024).”
To explore the mechanics behind these improvements, the authors conducted statistical tests to see if the clinical gains were tied to the presence of ketones or simply to weight loss. They found that higher levels of blood ketones strongly correlated with greater reductions in hemoglobin A1c and depressive symptoms.
Changes in body weight did not correlate with these specific metabolic or psychiatric improvements. “Also, we wondered throughout the trial if benefits would be due solely to weight loss,” Ford said. “We were gratified to find that the improvement in depressive symptoms and metabolic health was not related to weight loss but to ketone levels, even in the one-month RCT.”
The study design involves a few elements that could influence how the outcomes are interpreted. “There are a couple of caveats,” Ford noted. “First, it’s important to note that we did not have a control group for the four-month extension of the study, meaning all significant improvements we observed in neuropsychiatric symptoms and cognition were in a single-arm design. This indicates the need for longer-term RCTs to explore these effects.”
Because the control group did not receive catered meals, the ketogenic diet group had an inherent advantage in accessing free, easily prepared food that included fresh vegetables and proteins. “Second, we only provided meals to the ketogenic diet group, while the diet-as-usual group followed their regular diet,” Ford said. “As a result, we can’t rule out that meal provision itself contributed to some of the observed benefits. We recommend that future studies address this variable in their design.”
The study relied on a relatively small sample size, which prevented the authors from testing complex statistical models or separating the outcomes by specific psychiatric diagnoses. Certain physiological measurements were not tracked during the trial. The blood tests did not assess markers like cholesterol or detailed electrolyte balances.
These omitted measures are important for evaluating long-term cardiovascular health and the risk of developing kidney stones on a high-fat diet. The research team also did not track adjustments to participants’ psychiatric medications throughout the study.
Future research could benefit from longer monitoring periods and larger sample sizes to clarify how dietary interventions interact with standard psychiatric treatments.
“Our results are really promising, indicating that a ketogenic diet is feasible and safe in patients with serious mental illness, and our single-arm extension findings also indicate that the ketogenic diet may be beneficial for alleviating depression and schizophrenia symptoms,” Ford concluded. “We hope to see more funding being made available for RCTs that follow larger groups of patients for longer periods of time to establish whether the ketogenic diet is an effective treatment strategy for serious mental illness.”
The study, “Metabolic Improvements with a Ketogenic Diet Correlate with Symptom Improvement in Psychosis: A Randomized Controlled Trial,” was authored by Samantha V. Abram, Juliette M. Kyner, An Vu, Zanib Naeem, Shebani Sethi, Michael S. Jacob, Susanna L. Fryer, Daniel H. Mathalon, and Judith M. Ford.
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #KetogenicDiet #MetabolicHealth #Psychosis #Schizophrenia #BipolarDisorder #Ketones #DepressionSymptoms #MentalHealthDiet #Neuropsychiatry #SchizophreniaBullets
-
DATE: August 8, 2026 at 08:00AM
SOURCE: PSYPOST.ORG** Research quality varies widely from fantastic to small exploratory studies. Please check research methods when conclusions are very important to you. **
-------------------------------------------------TITLE: Ketogenic diet improves metabolic health and may reduce symptoms in schizophrenia and bipolar disorder
A recent study published in the Schizophrenia Bulletin suggests that a ketogenic diet provides metabolic and psychiatric benefits for individuals diagnosed with schizophrenia or bipolar disorder. The research indicates that shifting the brain’s primary fuel source from carbohydrates to fat derivatives called ketones tends to improve markers of blood sugar regulation. The findings also provide evidence that adopting this diet is associated with reduced symptoms of depression and psychosis over time.
People diagnosed with psychotic disorders frequently experience impaired cognitive function and disrupted daily living. The psychiatric medications typically prescribed to manage these conditions tend to induce high rates of metabolic dysfunction. These physical side effects often include elevated blood sugar, weight gain, and an increased risk of developing metabolic syndrome.
Metabolic syndrome involves a cluster of risk factors, such as high blood pressure and elevated fasting glucose, which correlate with shorter lifespans and more severe psychiatric symptoms. Diet plays a large role in the onset of this syndrome, and individuals with schizophrenia often face lifestyle challenges that make traditional nutritional management difficult.
The ketogenic diet is a nutritional approach composed of roughly 70 percent fat, 20 percent protein, and 10 percent carbohydrates. By severely restricting carbohydrate intake, the diet forces the body to break down fat into molecules known as ketone bodies. These ketone bodies provide an alternative energy source for cells.
Laboratory studies suggest that ketone metabolism yields more energy than glucose metabolism, which might help counteract the dysfunctional glucose processing often observed in the brains of individuals with schizophrenia. Previous case reports and uncontrolled studies provide evidence that the ketogenic diet can alleviate metabolic syndrome and psychiatric symptoms in various mental health conditions.
“A number of pilot studies have signaled the promise of a ketogenic diet as a treatment of serious mental health, but to attribute these positive effects to the diet rather than any other factors we still need randomized controlled trials (RCTs) comparing the ketogenic diet to another diet,” said Judith M. Ford, a professor in the Department of Psychiatry and Behavioral Sciences at the University of California, San Francisco. “Our study was a first attempt to directly make this comparison in participants with schizophrenia-spectrum or bipolar-1 disorder.”
The researchers recruited adult participants who met the diagnostic criteria for schizophrenia, schizoaffective disorder, or bipolar disorder with psychotic features. The research began with 58 participants who were randomly assigned to either a ketogenic diet group or a diet-as-usual control group for a one-month period.
Participants in the ketogenic diet group received 18 microwavable meals each week from a contracted delivery service. They were instructed to consume at least two provided meals a day and keep their overall carbohydrate intake below 10 percent. The diet-as-usual group was asked to continue their typical eating habits and did not receive prepared meals. Both groups received weekly check-in calls from a licensed dietitian.
The researchers measured several physiological variables, including body weight, insulin resistance, and hemoglobin A1c, which is a protein that reflects average blood sugar levels over several months. The authors also measured cognitive performance and psychiatric symptoms, such as depression and the positive and negative symptoms of psychosis. The analytical models adjusted for participants’ initial baseline scores to ensure that any observed changes were not due to preexisting differences between the groups.
At the end of the one-month trial, individuals in the ketogenic diet group demonstrated metabolic improvements compared to those eating their usual diet. Based on objective blood tests, the ketogenic group successfully reached and maintained standard nutritional ketosis. “We also showed that this diet is highly feasible in this population, with 83 percent of daily-tested participants maintaining ketosis in the one-month RCT portion of the study,” Ford noted.
Compared to the diet-as-usual group, participants on the ketogenic diet experienced a relative decrease in body mass index and lower levels of both hemoglobin A1c and insulin resistance. For instance, the ketogenic diet participants saw a moderate absolute reduction in their body weight and blood sugar markers, whereas the control group experienced nearly no change. Cognitive performance and symptoms of psychosis did not differ between the two groups at the end of the first month.
Partway through the trial, the researchers secured funding to offer an extended four-month ketogenic diet phase to all participants. A total of 25 individuals completed this extended dietary protocol. “Adherence to the diet was also high in this extension period (94 percent), with no reports of significant side effects from the diet,” Ford explained.
“I don’t know if this surprised us, but we were really encouraged to see the high feasibility of this diet in an outpatient population of patients with schizophrenia-spectrum or bipolar-1 disorder,” Ford said. “A common assumption we hear is that the diet must be too difficult for participants with severe mental illness to adhere to, but 25 of the participants opted to continue on the diet beyond the one-month RCT.”
This level of adherence suggests that lifestyle interventions are possible for this population when adequate resources are provided. “This choice to extend demonstrates the viability of this diet as a long-term intervention, along with support from our team, which included providing them with 18 microwavable ketogenic meals per week via a specialized delivery service, an initial coaching session, and support from a dietitian or research assistant,” Ford added.
Because there was no active control group for this extension phase, the researchers assessed changes by comparing the participants’ metabolic and psychiatric measurements at the four-month mark directly against their initial baseline scores. “The most notable effects in this study were the significant metabolic improvements in the ketogenic diet group compared with the control group in the RCT part of the trial,” Ford said.
After four months on the ketogenic diet, participants demonstrated enhanced cognitive performance and reductions in both the positive and negative symptoms of schizophrenia. They also experienced a marked reduction in depressive symptoms. Measurements of body mass index and hemoglobin A1c remained lower than their initial baseline levels.
“While we also saw significant improvements in depression, schizophrenia symptoms, and cognitive performance after four months on the ketogenic diet, we can’t attribute those effects to the specific diet, as it was offered to all participants at this stage,” Ford cautioned.
Readers might wonder why cognitive benefits did not appear earlier in the trial. Ford clarified this timeline, referencing similar clinical observations from other recent diet studies. “We weren’t able to see neuropsychiatric or cognitive benefits of the ketogenic diet after only one month on the diet, indicating that participants may need a longer time on the ketogenic diet for those benefits to emerge,” Ford said. “This is consistent with other similarly-sized single-arm pilot studies such as Volek et al. (2025), Campbell et al. (2025), and Sethi et al. (2024).”
To explore the mechanics behind these improvements, the authors conducted statistical tests to see if the clinical gains were tied to the presence of ketones or simply to weight loss. They found that higher levels of blood ketones strongly correlated with greater reductions in hemoglobin A1c and depressive symptoms.
Changes in body weight did not correlate with these specific metabolic or psychiatric improvements. “Also, we wondered throughout the trial if benefits would be due solely to weight loss,” Ford said. “We were gratified to find that the improvement in depressive symptoms and metabolic health was not related to weight loss but to ketone levels, even in the one-month RCT.”
The study design involves a few elements that could influence how the outcomes are interpreted. “There are a couple of caveats,” Ford noted. “First, it’s important to note that we did not have a control group for the four-month extension of the study, meaning all significant improvements we observed in neuropsychiatric symptoms and cognition were in a single-arm design. This indicates the need for longer-term RCTs to explore these effects.”
Because the control group did not receive catered meals, the ketogenic diet group had an inherent advantage in accessing free, easily prepared food that included fresh vegetables and proteins. “Second, we only provided meals to the ketogenic diet group, while the diet-as-usual group followed their regular diet,” Ford said. “As a result, we can’t rule out that meal provision itself contributed to some of the observed benefits. We recommend that future studies address this variable in their design.”
The study relied on a relatively small sample size, which prevented the authors from testing complex statistical models or separating the outcomes by specific psychiatric diagnoses. Certain physiological measurements were not tracked during the trial. The blood tests did not assess markers like cholesterol or detailed electrolyte balances.
These omitted measures are important for evaluating long-term cardiovascular health and the risk of developing kidney stones on a high-fat diet. The research team also did not track adjustments to participants’ psychiatric medications throughout the study.
Future research could benefit from longer monitoring periods and larger sample sizes to clarify how dietary interventions interact with standard psychiatric treatments.
“Our results are really promising, indicating that a ketogenic diet is feasible and safe in patients with serious mental illness, and our single-arm extension findings also indicate that the ketogenic diet may be beneficial for alleviating depression and schizophrenia symptoms,” Ford concluded. “We hope to see more funding being made available for RCTs that follow larger groups of patients for longer periods of time to establish whether the ketogenic diet is an effective treatment strategy for serious mental illness.”
The study, “Metabolic Improvements with a Ketogenic Diet Correlate with Symptom Improvement in Psychosis: A Randomized Controlled Trial,” was authored by Samantha V. Abram, Juliette M. Kyner, An Vu, Zanib Naeem, Shebani Sethi, Michael S. Jacob, Susanna L. Fryer, Daniel H. Mathalon, and Judith M. Ford.
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #KetogenicDiet #MetabolicHealth #Psychosis #Schizophrenia #BipolarDisorder #Ketones #DepressionSymptoms #MentalHealthDiet #Neuropsychiatry #SchizophreniaBullets
-
Deputies: Search underway in Upstate for man with schizophrenia, dementia
GREENWOOD COUNTY, S.C. (FOX Carolina) – Deputies with the Greenwood County Sheriff’s Office said they are searching for…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Mentalhealth #dementia #greenwood #harper #Health #highlandforestdrive #MentalHealth #missing #schizophrenia #sheriff #teddyharper
https://www.newsbeep.com/us/800338/ -
Deputies: Search underway in Upstate for man with schizophrenia, dementia
GREENWOOD COUNTY, S.C. (FOX Carolina) – Deputies with the Greenwood County Sheriff’s Office said they are searching for…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Mentalhealth #dementia #greenwood #harper #Health #highlandforestdrive #MentalHealth #missing #schizophrenia #sheriff #teddyharper
https://www.newsbeep.com/us/800338/ -
https://www.europesays.com/uk/1127141/ Deputies: Search underway in Upstate for man with schizophrenia, dementia #Dementia #greenwood #Harper #Health #HighlandForestDrive #MentalHealth #missing #schizophrenia #sheriff #TeddyHarper #UK #UnitedKingdom
-
https://www.europesays.com/ie/617460/ Deputies: Search underway in Upstate for man with schizophrenia, dementia #dementia #Éire #greenwood #harper #Health #HighlandForestDrive #IE #Ireland #MentalHealth #MentalHealth #missing #Schizophrenia #sheriff #TeddyHarper
-
https://www.europesays.com/ie/609690/ A Northland man falsely claimed his ex was on meds for schizophrenia. He was granted custody #after #barred #Child #claimed #contact #custody #Éire #ex #falsely #for #former #from #granted #he #Health #his #IE #Ireland #judge #man #Medication #meds #MentalHealth #MentalHealth #northland #on #partner #prescribed #Schizophrenia #unsupervised #was #with #woman #young
-
Sleep Spindles at One Electrode Site Flag Schizophrenia With Near-Perfect Accuracy in Small Pilot Study
Share if you found this interesting.
https://1ban.news/sleep-spindles-c3-schizophrenia-biomarker-pilot-mizuki-2026/
#1ban #sleep #spindles #schizophrenia #biomarker #neuroscience
-
Sleep Spindles at One Electrode Site Flag Schizophrenia With Near-Perfect Accuracy in Small Pilot Study
Share if you found this interesting.
https://1ban.news/sleep-spindles-c3-schizophrenia-biomarker-pilot-mizuki-2026/
#1ban #sleep #spindles #schizophrenia #biomarker #neuroscience
-
Sleep Spindles at One Electrode Site Flag Schizophrenia With Near-Perfect Accuracy in Small Pilot Study
Share if you found this interesting.
https://1ban.news/sleep-spindles-c3-schizophrenia-biomarker-pilot-mizuki-2026/
#1ban #sleep #spindles #schizophrenia #biomarker #neuroscience
-
Sleep Spindles at One Electrode Site Flag Schizophrenia With Near-Perfect Accuracy in Small Pilot Study
Share if you found this interesting.
https://1ban.news/sleep-spindles-c3-schizophrenia-biomarker-pilot-mizuki-2026/
#1ban #sleep #spindles #schizophrenia #biomarker #neuroscience
-
July 26 2026
Americans with Disabilities Act was signed into law on this day in 1990 it is 36 years old to today.
Today many disabled people look at the Americans with Disabilities Act as a great first step and a stepping stone and believe we could do better by our Americans leaving with disabilities. And we could stand to do better.
#aGlimpseAtMe #abuse #ADA #ADHD #Advocate #allMeaningful #AmericansWithDisabilitiesAct #Animals #AspergerSSyndrome #Author #Autism #awareness #bestFriend #bullying #burnout #care #clubFoot #compassion #desire #developmentOfSkill #didYouKnow #disabilities #disabilityHistoryAndPride #DisabilityPrideMonth #dos #dwarfism #education #event #freedom #getToKnowMe #goals #Gratitude #help #Life #love #LoveAndSupport #migraines #National #parents #pride #progress #PTSD #reflections #schizophrenia #selfCare #SpinaBifida #storyTelling #support #triggers #Wellbeing #Wisconsin #writing -
July 26 2026
Americans with Disabilities Act was signed into law on this day in 1990 it is 36 years old to today.
Today many disabled people look at the Americans with Disabilities Act as a great first step and a stepping stone and believe we could do better by our Americans leaving with disabilities. And we could stand to do better.
#aGlimpseAtMe #abuse #ADA #ADHD #Advocate #allMeaningful #AmericansWithDisabilitiesAct #Animals #AspergerSSyndrome #Author #Autism #awareness #bestFriend #bullying #burnout #care #clubFoot #compassion #desire #developmentOfSkill #didYouKnow #disabilities #disabilityHistoryAndPride #DisabilityPrideMonth #dos #dwarfism #education #event #freedom #getToKnowMe #goals #Gratitude #help #Life #love #LoveAndSupport #migraines #National #parents #pride #progress #PTSD #reflections #schizophrenia #selfCare #SpinaBifida #storyTelling #support #triggers #Wellbeing #Wisconsin #writing -
July 26 2026
Americans with Disabilities Act was signed into law on this day in 1990 it is 36 years old to today.
Today many disabled people look at the Americans with Disabilities Act as a great first step and a stepping stone and believe we could do better by our Americans leaving with disabilities. And we could stand to do better.
#aGlimpseAtMe #abuse #ADA #ADHD #Advocate #allMeaningful #AmericansWithDisabilitiesAct #Animals #AspergerSSyndrome #Author #Autism #awareness #bestFriend #bullying #burnout #care #clubFoot #compassion #desire #developmentOfSkill #didYouKnow #disabilities #disabilityHistoryAndPride #DisabilityPrideMonth #dos #dwarfism #education #event #freedom #getToKnowMe #goals #Gratitude #help #Life #love #LoveAndSupport #migraines #National #parents #pride #progress #PTSD #reflections #schizophrenia #selfCare #SpinaBifida #storyTelling #support #triggers #Wellbeing #Wisconsin #writing -
July 26 2026
Americans with Disabilities Act was signed into law on this day in 1990 it is 36 years old to today.
Today many disabled people look at the Americans with Disabilities Act as a great first step and a stepping stone and believe we could do better by our Americans leaving with disabilities. And we could stand to do better.
#aGlimpseAtMe #abuse #ADA #ADHD #Advocate #allMeaningful #AmericansWithDisabilitiesAct #Animals #AspergerSSyndrome #Author #Autism #awareness #bestFriend #bullying #burnout #care #clubFoot #compassion #desire #developmentOfSkill #didYouKnow #disabilities #disabilityHistoryAndPride #DisabilityPrideMonth #dos #dwarfism #education #event #freedom #getToKnowMe #goals #Gratitude #help #Life #love #LoveAndSupport #migraines #National #parents #pride #progress #PTSD #reflections #schizophrenia #selfCare #SpinaBifida #storyTelling #support #triggers #Wellbeing #Wisconsin #writing -
CW: Mention of psychosis, mention of psychotic triggers, passing mention of drugs
One aspect of #disability #accessibility that I feel is criminally overlooked is being mindful of #schizophrenia and other psychotic disorders.
Please, please don't joke around with common psychotic triggers, at least without a clear content warning on it. It's not funny.
Examples?
Any absurdist shitposting that implies common psychotic narratives (stalking, shadow people, cryptids, paranoia, mind control, fake reality etc.), especially if deliberately directed at the reader!
Even worse if it's trying to use a meta level to 'convince' the reader that they can't trust their senses or logic! It's not funny. You're attacking someone's only coping mechanism to ground themselves right after triggering them.
The whole "they're in my walls" meme, for instance. Or the "the curse is now lifted/back" one. Or the one that insinuates someone is trapped in a coma and people are trying to send messages via these memes to wake them up or whatever.
Or that #Fediverse joke that inserts someone's name or instance into a post (i. e. "anyone else see John Doe around everywhere lately??", where John Doe is automatically changed to the reader's name by exploiting the protocol), is just as bad.
All of these can and will actually hospitalise people, or worse!!
Psychosis is not a super rare condition. I myself experienced an isolated psychotic episode a couple of years ago after a #THC overdose.
Example of someone hospitalised because of a TV ad that happened to use her name:
https://www.dexerto.com/tv-movies/woman-hospitalized-after-pluribus-ad-on-smart-fridge-triggers-psychotic-episode-3290678/There are no words to describe how absurdly terrifying it can be to exist as a consciousness that can't trust its inputs anymore, whose compulsive trains of thought are working against itself.
Please, if you consider yourself a progressive or just a kind person, try to think a bit about this before posting. And use a content warning if you're unsure.